Northern Trust’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$236K Sell
33,333
-412
-1% -$2.91K ﹤0.01% 3895
2025
Q4
$167K Hold
33,745
﹤0.01% 4038
2025
Q3
$152K Sell
33,745
-11,811
-26% -$40.2K ﹤0.01% 4050
2025
Q2
$142K Buy
45,556
+434
+1% +$1.22K ﹤0.01% 4031
2025
Q1
$113K Sell
45,122
-3,544
-7% -$11.1K ﹤0.01% 4087
2024
Q4
$151K Buy
48,666
+25,770
+113% +$66K ﹤0.01% 4069
2024
Q3
$54.5K Sell
22,896
-376
-2% -$832 ﹤0.01% 4188
2024
Q2
$58.9K Sell
23,272
-1,470
-6% -$3.74K ﹤0.01% 4185
2024
Q1
$73K Sell
24,742
-3,192
-11% -$9.8K ﹤0.01% 4155
2023
Q4
$84.1K Buy
+27,934
New +$89.9K ﹤0.01% 4145

Other funds holding DRTS

Northern Trust's DRTS Position: Q1 2026 in Review

Northern Trust reduced its Alpha Tau Medical (DRTS) stake by 1.2% in Q1 2026, selling an estimated $2.91K and leaving 33,333 shares worth $236K. The position accounts for ﹤0.01% of the portfolio, ranked #3895.

Northern Trust first reported a position in DRTS in Q4 2023 and has held it in 10 quarters since. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

  • Northern Trust held 33,333 shares of Alpha Tau Medical worth $236K as of Q1 2026.
  • Northern Trust sold 412 Alpha Tau Medical shares in Q1 2026, an estimated $2.91K.
  • Alpha Tau Medical made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3895 holding.
  • Northern Trust first reported a position in Alpha Tau Medical in Q4 2023 and has held it in 10 quarters since.
  • 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.